BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 261 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,524 | +1.0% | 32,695 | -11.1% | 0.01% | 0.0% |
Q1 2024 | $3,489 | +9.9% | 36,777 | +6.8% | 0.01% | +25.0% |
Q4 2023 | $3,175 | +70.5% | 34,426 | -7.1% | 0.00% | +33.3% |
Q3 2023 | $1,862 | -15.8% | 37,074 | +5.9% | 0.00% | 0.0% |
Q2 2023 | $2,212 | +17.3% | 34,996 | -16.5% | 0.00% | 0.0% |
Q1 2023 | $1,886 | -18.1% | 41,925 | -20.3% | 0.00% | 0.0% |
Q4 2022 | $2,303 | -99.9% | 52,575 | +5.6% | 0.00% | -40.0% |
Q3 2022 | $3,280,000 | +45.4% | 49,779 | +11.5% | 0.01% | +66.7% |
Q2 2022 | $2,256,000 | -30.0% | 44,658 | -11.5% | 0.00% | 0.0% |
Q1 2022 | $3,225,000 | -37.8% | 50,478 | +4.2% | 0.00% | -40.0% |
Q4 2021 | $5,188,000 | +3.7% | 48,436 | -0.5% | 0.01% | 0.0% |
Q3 2021 | $5,003,000 | -1.8% | 48,662 | -16.0% | 0.01% | 0.0% |
Q2 2021 | $5,095,000 | -9.6% | 57,923 | -0.0% | 0.01% | -16.7% |
Q1 2021 | $5,634,000 | -13.3% | 57,950 | 0.0% | 0.01% | -14.3% |
Q4 2020 | $6,499,000 | +20.5% | 57,950 | -0.4% | 0.01% | 0.0% |
Q3 2020 | $5,395,000 | +20.7% | 58,200 | +1.6% | 0.01% | +16.7% |
Q2 2020 | $4,469,000 | +57.2% | 57,300 | +17.9% | 0.01% | +50.0% |
Q1 2020 | $2,842,000 | -19.2% | 48,600 | +10.7% | 0.00% | 0.0% |
Q4 2019 | $3,517,000 | -6.1% | 43,900 | -13.9% | 0.00% | -20.0% |
Q3 2019 | $3,747,000 | -26.9% | 51,000 | -6.1% | 0.01% | -16.7% |
Q2 2019 | $5,123,000 | +25.3% | 54,312 | +6.3% | 0.01% | +20.0% |
Q1 2019 | $4,089,000 | +86.8% | 51,077 | +25.8% | 0.01% | +66.7% |
Q4 2018 | $2,189,000 | -44.0% | 40,600 | -18.9% | 0.00% | -40.0% |
Q3 2018 | $3,910,000 | +23.0% | 50,086 | 0.0% | 0.01% | +25.0% |
Q2 2018 | $3,179,000 | -37.7% | 50,086 | -10.0% | 0.00% | -33.3% |
Q1 2018 | $5,103,000 | +32.6% | 55,649 | +9.0% | 0.01% | +20.0% |
Q4 2017 | $3,848,000 | +13.9% | 51,034 | +5.2% | 0.01% | +25.0% |
Q3 2017 | $3,379,000 | +49.2% | 48,507 | +8.6% | 0.00% | +33.3% |
Q2 2017 | $2,264,000 | +153.0% | 44,672 | +99.6% | 0.00% | +200.0% |
Q1 2017 | $895,000 | +55.7% | 22,383 | +9.2% | 0.00% | 0.0% |
Q4 2016 | $575,000 | -5.6% | 20,500 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $609,000 | +46.7% | 20,500 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $415,000 | +123.1% | 20,500 | +99.0% | 0.00% | – |
Q1 2016 | $186,000 | -31.4% | 10,300 | 0.0% | 0.00% | – |
Q4 2015 | $271,000 | +23.2% | 10,300 | 0.0% | 0.00% | – |
Q3 2015 | $220,000 | +36.6% | 10,300 | +69.1% | 0.00% | – |
Q2 2015 | $161,000 | – | 6,091 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |